Showing results (231-240 of 447) with videos related to
Sort By:
Pageof 45
Translational Lung Cancer Research|July 28, 2018
Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancerFederico Rotolo, Chang-Qi Zhu, Elisabeth Brambilla, et al.Journal of the National Cancer Institute|January 9, 2026
Targeting common EGFR mutations in NSCLC-review of global phase III trials of third-generation inhibitorsBarbara Melosky, Rosalyn A Juergens, Quincy S C Chu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 17, 2019
Outcomes of Long-term Interval Rescreening With Low-Dose Computed Tomography for Lung Cancer in Different Risk CohortsReenika Aggarwal, Andrew C L Lam, Maureen McGregor, et al.Oncotarget|November 22, 2017
Novel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenograftsIrene Brana, Nhu-An Pham, Lucia Kim, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 17, 2020
Minimalist approaches to cancer tissue-of-origin classification by DNA methylationDaniel Xia, Alberto Jose Leon, Michael Cabanero, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
Patient-Derived Xenograft Establishment from Human Malignant Pleural MesotheliomaLicun Wu, Ghassan Allo, Thomas John, et al.Immunity|January 30, 2021
Early innate and adaptive immune perturbations determine long-term severity of chronic virus and Mycobacterium tuberculosis coinfectionWenxi Xu, Laura M Snell, Mengdi Guo, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 13, 2014
Sample features associated with success rates in population-based EGFR mutation testingCarolyn J Shiau, Jesse P Babwah, Gilda da Cunha Santos, et al.JTO Clinical and Research Reports|March 20, 2026
Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and StrategiesMontse Sanchez-Cespedes, William W Lockwood, Kenichi Suda, et al.Lung Cancer (Amsterdam, Netherlands)|May 1, 2021
Durability of CNS disease control in NSCLC patients with brain metastases treated with immune checkpoint inhibitors plus cranial radiotherapySally C M Lau, Christopher Poletes, Lisa W Le, et al.Pageof 45